RESEARCH GRANT AWARDS
AWARDS LIST.
Totals by Year
2024 - 1,139,000
2023 - $891,364
2022 - $1,199,966
2021 - $749,812
2020 - $630,000
2019 - $690,000
2018 - $750,000
2017 - $747,772
2016 - $720,000
2015 - $840,000
2014 - $810,000
2013 - $808,500
2012 - $720,000
2011 - $599,780
2010 - $438,000
2009 - $435,000
2008 - $619,993
2007 - $232,600
2006 - $384,551
Amounts flagged (*) below are funded by Cancer League of Colorado and a generous matching grant from MDC/Richmond American Homes Foundation
Reema Wahdan, PhD and Daniel LaBarbera, PhD
Targeting Thyroid Hormone-Mediated Cancer Stem Cell Expansion and Treatment Resistance in ER+ Breast Cancer cells
$60,000
2022
Joselyn Cruz Cruz, PhD
Reversing Immunosuppression in Rhabdomyosarcoma
$ 30,000
2022
Jeffrey Moore, PhD
Mechanism of Chemotherapeutic Resistance by TUBB3 Tubulin
$30,000
2022
Shi-Long Lu, MD, PhD and Daniel Frank, PhD
Functional assessment of human microbiome in head and neck cancer mouse models
$60,000
2022
Takeshi Yamauchi, PhD
Non-UV risk factors of melanoma
$30,000
2021
Siddhartha Mitra, PhD
Development of Chimeric Antigen Receptor Expressing macrophages and microglia to target pediatric glioblastoma
$30,000
2021
Rajeev Vibhakar, MD, PhD, MPH
Role of BMI1 in SMARB1 deleted ATRTs
$30,000
2021
Masanori Hayashi, MD
Preclinical Investigation of BCOR rearranged solid tumors
$30,000
2021
Matthew J. Sikora, PhD
Targeting an unexplored DNA repair deficiency and radiosensitivity in lobular breast cancer
$30,000
2021
Carol Sartorius, PhD
Lipodependence of endocrine resistant breast cancer as a therapeutic target
$30,000
2021
John Tentler, PhD
Cancer Research Summer Fellowship Program
$30,000
2021
Satyanarayan Rao, PhD
Using transcription factors to map tumor state and microenvironment
$30,000
2021
Jennifer Matsuda, PhD and James Scott-Browne, PhD
Genetic manipulation of human T cell transcriptional programs to improve cancer immunotherapy
$60,000
2021
Leonora Slatnick, MD
Biomarker Development for Sepsis in Pediatric Oncology Patients
$30,000
2021
Carlo Marchetti, PhD and Mayumi Fujita, MD, PhD
Identifying the role of NLRP3 in immunotherapy resistant melanomas
$60,000
2021
Andrew Getahun, PhD and John Cambier, PhD
Identification of novel inhibitory checkpoint receptors
$60,000
2021
Adam Green, MD and Natalie Serkova, PhD and Mark Borden, PhD
MRI-Guided Focused Ultrasound to Improve Treatment of DIPG
$60,000
2021
Sujatha Venkataraman, PhD
Novel CAR T cell therapies to target metastatic Ewing Sarcoma
$30,000
2021
Paul Jedlicka, MD, PhD
Understanding the metastasis-promoting cistrome in Ewing Sarcoma
$30,000
2021
Santos Franco, PhD, Siddhartha Mitra, PhD and Adam Green, MD
Development of In utero driven Mouse Models of Diffused Midline Gliomas to study the tumor immune interactions in Pediatric Midline Gliomas
$60,000
2021
Elizabeth Kessler, MD
Validation of a patient-reported tool to screen for geriatric impairments predictive of potential frailty in cancer patients
$29,812
2021
Dr. Michael Veneris and C. Wyatt Shields, PhD
Assessment of Cell Types for Delivering MerTK Inhibitors to Sarcomas
$60,000
2021
Nathan Dahl, MD
Unlocking the combination: Potentiation of radiation-induced antitumor effect using clinically-relevant BH3 mimetics to effectively target DIPG
$30,000
2021
Paula Jedlicka, MD, PhD
Understanding and targeting highly metastatic EWS/FLi1-low cells in Ewing Sarcoma
$ 30,000
2020
Ryan Marker, PhD
Feasibility and effectiveness of an Innovative exercise program to reduce fatigue in rural cancer survivors
$ 30,000
2020
Zdenek Andrysik PhD
Exploring strong synergism of targeted p53 activation and translation inhibition in colorectal cancer.
$ 30,000
2020
Senthilnath Lakshmana Chetty, PhD
Combining radiation and Immunotherapy to target diffuse midline gliomas with the H3K27M mutation
$ 30,000
2020
Breelyn Wilky, MD & Eduardo Davila, PhD
Toxicity and Biodistribution of CD*:MyD88 Engineered Autologous T Cells In Mouse Models of Melanoma and Fibrosarcoma
$ 60,000
2020
Zachary Graff, MD
Development of Bispecific CAR T-cells for the Prevention of Lineage Switch in KMT2A-rearranged Leukemia
$ 30,000
2020
Swati G. Patel, MD, MS
Identification of Hereditary Cancer Syndromes through Advanced Polyps
$ 30,000
2020
Molishree Joshi, PhD
A novel CRISPR-mediated tumor targeting strategy for Liiposarcoma
$ 30,000
2020
Matthew Tallaferro, PhD
Control of cell division through centrosomal RNA localization
$ 30,000
2020
Diana M. Cittelly, PhD
Function of Ephrin B Signaling in Breast cancer brain metastasis
$ 30,000
2020
Rebecca Schweppe, PhD
The role of Nuclear FAK in Thyroid Cancer
$ 30,000
2020
Maureen Lynch, Phd & Philip Owens, PhD
The role of exercise in breast cancer bone metastasis
$ 60,000
2020
Christine Towers, PhD
Identifying novel regulators of mitochondrial turn over
$ 30,000
2020
Sujatha Venkataraman PhD & Adam Green, MD & Mark Kohler, MD, PhD
Engineering Logic-Gated DC99 CAR to selectively target H3K27M-DIPG tumor cells and to protect normal cells
$ 60,000
2020
Mayumi Fujita, MD, PhD & Charles A. Dinarello, MD
The role of alpha-1 antitrypsin in cancer immunotherapy
$ 60,000
2020
Raphael Nemenoff, PhD & Erin Schenk, MD, PhD
The Tumor Microenvironment as a Critical Regulator of Targeted Therapy in ALK Positive Lung Cancer
$ 60,000
2020
Heather Brechbuhl, PhD
Defining reversible tumor traits in the obese microenvironment
$ 30,000
2019
Carol Sartorius, PhD
PR-RAR downregulation of protein synthesis and cell growth in breast cancer
$ 30,000
2019
Cem Altunbas, PhD
High-fidelity volumetric imaging for quantitative treatment monitoring and modifications in radiation therapy
$ 30,000
2019
Isabel Schlaepfer, PhD
Role of fat oxidation via CPT1A in immunological response to prostate cancer
$ 30,000
2019
Paul Norman, PhD
Natural Killer cells can protect from developing leukemia
$ 30,000
2019
Zachary Levi Watson, PhD
Targeting histone acetylation in PARP inhibitor-resistant ovarian cancer
$ 30,000
2019
John Tentler, PhD
Cancer Research Summer Fellowship Program
$ 30,000
2019
Adam Mueller, MD, PhD
Investigating crosstalk between ADAM10 and EphrinB2/EPHB4 in mediating radiation induced fibrosis, invasion and metastasis in pancreatic cancer
$ 30,000
2019
Jay Hesselberth, PhD
Single-cell methods to measure functional heterogeneity
$ 30,000
2019
Sujatha Venkataraman, PhD and Mark Kohler, MD, PhD
CD99 targeting CAR T cells as a novel therapy for H3K27M mutant DIPG
$ 60,000
2019
Shi-Long Lu, MD, PhD and Daniel Frank, PhD
Mechanism of oral microbiota in head and neck cancer pathogenesis and application for targeted therapy
$ 60,000
2019
Yiqun Shellman, PhD & Martin McCarter, MD
Targeting anti-apoptotic pathways to improve immunotherapies for melanoma
$ 60,000
2019
Mayumi Fujita, MD, PhD & Donald Backos, PhD
Somatic mutations in inflammasome genes in melanoma
$ 60,000
2019
Neil Box, PhD
Regulation of p53 in tanning
$ 30,000
2019
Neelanjan Mukherjee, PhD & Daniel Sherbenou, MD, PhD
Exploiting mRNA translation inhibition for the treatment of relapsed/refractory multiple myeloma
$ 60,000
2019
Rajeev Vibhakar, MD, PhD, MPH
Role of CDK7 in medulloblastoma
$ 30,000
2019
Stephen Keysar, PhD
Targeting of stemness factors and fusion proteins in salivary gland cancers through inhibition of translation elongation
$ 30,000
2019
Matthew Sikora, PhD
Defining MDC1 as a central regulator of estrogen receptor and DNA repair in lobular carcinoma
$ 30,000
2019
Jennifer DeLuca, PhD
Targeting Kinetochore Dysfunction in Cancer Cells
$ 30,000
2018
David Thomas, PhD and Mark Borden, PhD
X-Ray Acoustic Computed Tomography Guided Adaptive Radiotherapy
$ 30,000
2018
Maria Jose Contreras, PhD
Mechanisms of TDM1/radiation-induced toxicity in brain metastases
$ 30,000
2018
Nathan Dahl, MD
Oncogenic Role of the Super Elongation Complex in H3K27M-mutant Diffuse Midline Glioma
$ 30,000
2018
Adwitiya Kar, PhD and Margaret Wierman, MD
Targeting Maternal Embryonic Leucine Zipper Kinase (MELK) in the first pre-clinical models of Adrenocortical Carcinoma
$ 30,000
2018
Courtney Jones, PhD
Targeting relapse leukemia stem cells through inhibition of NAD synthesis
$ 30,000
2018
Mair E.A. Churchill, PhD
Inhibition of Chromatin Assembly Factor 1 B to Reverse Leukemogenesis
$ 30,000
2018
Jessica Lake, MD, MPH
IPS-derived, CAR-expressing Natural Killer Cells Targeting EGFR on Pediatric Sarcomas
$ 30,000
2018
Jill Slansky PhD
Functional activation of low-affinity T cells in the tumor
$ 30,000
2018
Raul M. Torres, PhD
Suppression of human CD8 T cell antigen receptor signaling and cytotoxic activity by lysophosphatidic acid
$ 30,000
2018
Christopher Lieu, MD and Todd Pitts, MD
Investigating the role of MEK and non-canonical Wnt inhibition in altering the immune microenvironment in metastatic colorectal cancer
$ 60,000
2018
Linda Van Dyk, PhD
Role of CDK4 and CDK6 in gammaherpesvirus oncogenesis
$ 30,000
2018
Benjamin Bitler, PhD
Investigating the mechanisms of EHMT1/2-dependent PARP inhibitor resistance
$ 30,000
2018
Jennifer Hintzsche, PhD
Patient-centric Multi-Omics Approach to Identifying Actionable Therapeutics in Cancer
$ 30,000
2018
Martin McCarter, MD
Improving immune checkpoint inhibitor efficacy by targeting myeloid-derived suppressor cell function
$ 30,000
2018
David Ryan Ormond MD
Diffusion tensor image tractography in surgical resection of glioblastoma resection and surgical safety
$ 30,000
2018
Zhangguo Chen, PhD
Elucidating mechanisms by which a newly developed HDAC inhibitor sensitizes B cell lymphomas to PD-1 therapy
$ 30,000
2018
John Tentler, PhD
Cancer Research Summer Fellowship Program
$ 30,000
2018